help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fallo, F.
Right arrow Articles by Sonino, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fallo, F.
Right arrow Articles by Sonino, N.

Journal of Clinical Endocrinology & Metabolism, Vol 79, 772-774, Copyright © 1994 by Endocrine Society

ARTICLES

Abnormality of aldosterone and cortisol late pathways in glucocorticoid- remediable aldosteronism

F Fallo, U Kuhnle, M Boscaro and N Sonino
Division of Endocrinology, University of Padova, Italy.

Patients with glucocorticoid-remediable aldosteronism (GRA) possess a chimeric gene resulting from fusion of the genes encoding steroid aldosterone synthase and 11 beta-hydroxylase. In the adrenal zona fasciculata, this may lead to ectopic expression under ACTH control of aldosterone synthase activity and increased formation of cortisol C18 oxidation products. We assessed mineralocorticoid and glucocorticoid pathways in three patients with GRA. Baseline plasma progesterone, 17 alpha-hydroxyprogesterone, corticosterone, and cortisol were normal in all patients, whereas 11-deoxycorticosterone, aldosterone, and 11- deoxycortisol were above normal. The ratios of both corticosterone/11- deoxycorticosterone and cortisol/11-deoxycortisol were abnormally low, and decreased further 60 min after administration of ACTH-(1-24) (250 micrograms) as an i.v. bolus. A low corticosterone/11- deoxycorticosterone ratio is consistent with an increased aldosterone synthase activity forming aldosterone by corticosterone. Similarly, a decreased cortisol/11-deoxycortisol ratio could reflect enhanced cortisol C18 oxidation. Our findings are in agreement with a hyperfunction of the 11 beta-hydroxylase/aldosterone synthase complex in the adrenal zona fasciculata of GRA induced by the new chimeric gene.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
A. Fisher, E. C. Friel, R. Bernhardt, C. Gomez-Sanchez, J. M. C. Connell, R. Fraser, and E. Davies
Effects of 18-Hydroxylated Steroids on Corticosteroid Production by Human Aldosterone Synthase and 11{beta}-Hydroxylase
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4326 - 4329.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Stowasser, M. G. Gartside, W. L. Taylor, T. J. Tunny, and R. D. Gordon
In Familial Hyperaldosteronism Type I, Hybrid Gene-Induced Aldosterone Production Dominates That Induced by Wild-Type Genes
J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3670 - 3676.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society